RAC1 and cutaneous melanoma: In a small subset of cutaneous melanomas, and in the vast majority of uveal melanomas, the activation of PAK1 is expected as a consequence of activating mutations in the GNAQ and GNA11 oncogenes, which reportedly signal through RAC1 and RAS [60,61].